Articles tagged with Vaccination
A new study by Mayo Clinic reveals that African-American individuals develop twice the antibody response to the rubella vaccine compared to Caucasians. This finding may enable the creation of vaccines tailored to specific ethnic groups or individuals, offering a more effective approach to immunization.
Research from the University of Kent found that stronger belief in anti-vaccine conspiracy theories is associated with lower intention to vaccinate. This study suggests that anti-vaccine conspiracy theories may present a barrier to vaccine uptake, posing significant consequences for children's health.
Researchers have discovered a novel immunological mechanism that regulates B lymphocytes to fight encapsulated bacteria, clearing the path for more efficient vaccines. This discovery improves our understanding of the immune system's protection against infections.
Researchers developed a vaccine against rodent skin papillomavirus that prevented benign and malignant skin tumors in vaccinated animals. The vaccine worked even when given to already infected animals and suppressed the virus in mice treated with immune-suppressive drugs.
A nationwide study found HPV vaccination significantly reduces risk of cervical atypia and CIN2/3 among Danish girls and women. Vaccination with the quadrivalent HPV vaccine is effective in reducing population-level cervical precursor lesion risk.
Research suggests common infections increase stroke risk in children by six times, but routine vaccinations can help decrease this risk. The study found that childhood vaccinations were associated with a lower stroke risk, particularly for those who received all or most vaccines.
A Swedish register study found that receiving three doses of HPV vaccine significantly reduces the incidence of genital warts compared to two doses. The study, published in JAMA, suggests that a three-dose regimen may be more effective in preventing genital warts than previously thought.
A study found that receiving two doses of the HPV vaccine significantly reduces the risk of genital warts and other STDs. The vaccine's efficacy was seen to decrease after three doses, but it still offers substantial protection against these diseases.
A new study published in Pediatrics reveals that HPV vaccine perceptions do not influence subsequent sexual behaviors in teenage girls and young women. The vast majority of participants maintained safer sex habits after vaccination, regardless of their beliefs about the vaccine's effectiveness.
A new adjuvant, IL-33, enhances the immune response to cancer cells and viruses. The protein is being studied as a potential boost for vaccines against pathogens.
Researchers developed a nasal vaccine formulation that provides protective immunity against West Nile virus in mice after only 2 doses. The vaccine was shown to protect 100% of mice from morbidity and weight loss.
Researchers developed a novel method to study enterovirus structures and functions, allowing for tracking of viruses in cells and tissues. The method involves attaching gold nanoparticles to viruses, enabling studies on structural changes and mechanisms of virus uncoating.
Research published in Neurology suggests that having shingles may increase the risk of having a stroke years later, especially in young adults. People aged 18-40 who had shingles were found to be at a higher risk of stroke, heart attack, or transient ischemic attack compared to those who did not have shingles.
The article discusses the use of unlicensed vaccine Bexsero to combat meningitis outbreaks in the US, as well as new guidelines for BRCA mutation screening in high-risk women. The American College of Physicians also explains how Medicaid expansion will benefit poor citizens and their physicians by increasing access to healthcare.
A new study reveals the BCG vaccine is highly protective against pulmonary TB globally, including in tropical regions. The key to its effectiveness lies in early vaccination before prior infection, suggesting a crucial role for BCG in controlling TB's major burden and transmission.
Researchers have developed an oral vaccine against Helicobacter pylori using Lactobacillus acidophilus as a delivery vehicle. The vaccine elicits specific antibodies and provides significant protection against gastric infection.
Researchers found that young natural killer cells play a key role in preventing infectious mononucleosis caused by Epstein-Barr Virus. A potential vaccination is being explored to protect against EBV infection and reduce the risk of developing Hodgkin lymphoma.
Researchers found that moderate drinking boosted the immune system of rhesus macaques, leading to enhanced responses to vaccines. In contrast, heavy drinkers showed diminished vaccine responses. The study suggests a potential link between moderate alcohol consumption and improved immune function.
A study analyzed how celebrities gain credibility as medical advisors and why the public follows their health advice. The researchers found that people's natural tendency to imitate others (herding) and celebrity endorsements can lead to a perception of trustworthiness, despite the lack of medical expertise.
A phase 2 trial of a personalized vaccine made from patient tumor tissue showed improved survival rates compared to standard care alone. The vaccine, HSPPC-96, triggered an immune response to kill remaining tumor cells after surgery.
The pertactin antigen, crucial to the effectiveness of the whooping cough vaccine, is now absent from more than half of US bacterial isolates. The absence of this antigen has significant implications for public health authorities and highlights the need to monitor circulating bacterial populations.
A study published in Neurology suggests that a vaccine used to prevent tuberculosis may help prevent multiple sclerosis in people showing early signs of the disease. After six months, vaccinated individuals had fewer brain lesions than those who received a placebo, with 58% not developing MS compared to 30%.
A UConn research team has found a way to stabilize hemoglobin, the oxygen carrier protein in the blood, by wrapping it in a polymer chain. This discovery could lead to the development of stable vaccines and affordable artificial blood substitutes.
A nanosponge vaccine has been developed to combat MRSA toxins, triggering neutralizing antibodies and fighting off lethal doses in mice. The vaccine was found to be safer and more effective than traditional toxoid vaccines made from heat-treated staph toxin.
The University of Pittsburgh's Project Tycho has digitized all weekly surveillance reports for reportable diseases in the US since 1888, revealing patterns and insights into vaccine effectiveness. The database contains data on eight vaccine-preventable diseases, showing a resurgence of some diseases despite vaccination efforts.
A review of medical literature reveals financial concerns, parental attitudes, and social influences as key barriers to HPV vaccination among adolescents. The study emphasizes the importance of targeted guidance for healthcare professionals to improve vaccine uptake.
A Phase I clinical trial found that eight out of 16 patients with glioblastoma multiforme survived longer than five years, with median overall survival at 38.4 months. The treatment used an ICT-107 vaccine to alert the immune system to cancer cells and activate a tumor-killing response.
A new study suggests that rotavirus vaccination can also protect children against seizures, with a reduced risk of 20% compared to unvaccinated children. The researchers found that fully vaccinated children had fewer seizure-related hospitalizations and emergency department visits.
The University of Illinois has won Grand Challenges Explorations grants to develop a single-dose vaccine for multiple animal diseases and a system to study the microscopic parasite Cryptosporidium. This funding aims to address pressing disease problems in developing nations, improving animal health and productivity.
Researchers identified a genetic signature for respiratory syncytial virus (RSV), which causes severe pneumonia and bronchiolitis in infants. The discovery will help develop a vaccine and improve disease severity prediction using RNA profiles.
A study published in Neurosurgery found significant variations in hospitals' management of children with traumatic brain injury, particularly in ICP monitoring and craniectomy. The study analyzed data from over 7,000 children treated at 156 US hospitals and found that rates of these interventions varied significantly between hospitals.
Researchers at Northwestern University have successfully tested a nontoxic therapy that suppresses Lupus in blood samples of people with the autoimmune disease. The study found that the peptides can block and reduce autoantibody production to almost baseline levels, showing potential as a vaccine-like therapy.
A recent study published in Cancer Prevention Research found that women vaccinated with one dose of the human papillomavirus (HPV) vaccine had stable antibodies against HPV viruses in their blood for up to four years. The results challenge previous dogma on protein subunit vaccines requiring multiple doses for long-lived responses.
The study found that HPV vaccine initiation and completion rates were consistently lowest in the South, with 14% and 6% of women completing the series, respectively. The researchers believe regional disparities may be due to factors such as income, education, and insurance coverage.
A new DNA vaccine, p(Aβ3–10)10-C3d-p28, was developed to induce a Th2 immune response against amyloid-beta in Alzheimer's disease mice. The vaccine successfully elicited high titers of anti-amyloid-β antibodies and shifted the cellular immune response towards a Th2 phenotype.
A new study published in Pediatrics found that widespread vaccination of adolescents for pertussis was linked to a modest reduction in infant hospitalizations. The research suggests increasing vaccination rates among teens and adults is crucial to stem the ongoing pertussis epidemic among infants.
Many parents believe the HPV vaccine is unnecessary or unsafe, which poses a barrier to its success. Experts argue that clinicians must engage with parents and address their concerns through open conversations and science-based information. Social media may also play a role in future HPV vaccination programs.
A special issue of Preventive Medicine explores common misconceptions about the HPV vaccine, including concerns about sexual disinhibition and vaccine safety. Studies show that these fears are largely unfounded, and that the vaccine can help prevent cervical cancer and other HPV-associated cancers.
A mass vaccination campaign of over 300,000 people in Guinea demonstrated the feasibility of using an oral cholera vaccine during a cholera outbreak. The campaign achieved high coverage rates and was well accepted by the local community.
A clinical study published in The Lancet Infectious Diseases shows that an oral cholera vaccine (ShancholTM) provides sustained protection against cholera in humans for up to five years. This breakthrough finding has significant implications for vaccination strategies and cost-effectiveness in developing countries.
A new study explores why low-income parents, particularly those from minority groups, may not be getting the human papillomavirus (HPV) vaccine. English-speaking parents expressed concerns about the vaccine's need and safety, while Spanish-speaking parents feared the vaccine would encourage sexual activity due to lack of provider expla...
A Kaiser Permanente study found that children whose parents used an integrated personal health record were twice as likely to attend all recommended well-child care visits. The study also found a positive correlation between PHR use and immunization receipt, although the results in Hawaii were statistically non-significant.
A recent study found no significant increase in serious diseases among HPV-vaccinated girls compared to unvaccinated peers, despite monitoring over 900,000 participants. The researchers also noted that mild adverse reactions such as fever and swelling are common but not considered a concern.
A universal infant vaccination campaign in China has led to a doubling of Hepatitis B virus (HBV) mutations, which may enable the virus to evade the vaccine. The mutations have risen from 6.5% in 1992 to nearly 15% in 2005, necessitating new vaccination strategies.
A study found that Haitians rely heavily on traditional healers and religious leaders for health information, but struggle with Western medicine and vaccination uptake. The research highlights the need for more coordinated efforts to provide healthcare to the Haitian population.
A study by Tel Aviv University researchers reveals that nearly all pediatricians in Israel strongly support the vaccination of infants, with 92% agreeing it is in their best interest. However, 37% also agree that parents have a right to decide on medical care for their children.
The National Institutes of Health has awarded a nearly $1 billion contract to Saint Louis University's Center for Vaccine Development, recognizing the institution's leadership role in vaccine research. The seven-year contract will support clinical trials and lab studies for new vaccines, with a focus on emerging threats.
The updated guidelines offer recommendations for vaccination of household pet cats, shelter house cats, and cats in breeding catteries based on risk assessment. The new protocols prioritize comprehensive physical examinations and consultation to determine each cat's specific vaccination requirements.
A clinical trial found that a booster dose of the new meningitis B vaccine at 40 months of age can overcome waning immunity induced by infant vaccination, showing high antibody levels in 89%–100% of children against most strains.
Researchers at A*STAR have discovered a new personalized treatment strategy that utilizes a patient's own blood to treat chronic infections. By harnessing the power of monocytes, white blood cells can capture and utilize viruses to boost the immune response.
Scientists found that vaccinating cattle against E. coli O157 could reduce human cases of infection by nearly 85%, a significant improvement over previous estimates. The researchers used veterinary, human, and molecular data to estimate the impact of vaccinating cattle and predict that it would have a major public health benefit.
Researchers at Indiana University have developed a novel vaccine that effectively reduces the shedding of genital herpes virus, potentially providing a new treatment option for those affected. The vaccine, GEN-003, is one of the first to target viral shedding, which is often how the disease is spread.
A study by Jason M. Glanz and colleagues found that undervaccination with the DTaP vaccine increases the risk of pertussis in children aged 3-36 months. The research involved 72 cases of pertussis and 288 controls, showing that undervaccinated children were 18.56 times more likely to contract the disease than their vaccinated peers.
A study found that one-third of Walgreens vaccinations are administered during off-clinic hours, particularly among younger, healthy adults. This shift in vaccination access could measurably increase immunization rates in the US. Additionally, a new study suggests that eligible Medicaid beneficiaries under the Patient Protection and Af...
The nationwide HBV immunization program, launched in 1984, successfully lowered chronic HBV carrier prevalence, HCC incidence, and mortality of infant fulminant hepatitis in vaccinated birth cohorts. Long-term high-coverage immunization was associated with increased herd immunity and lower IFH mortality rates.
The study found that different PCV immunization schedules resulted in similar antibody levels in infants, with some schedules being superior for specific serotypes. The researchers conclude that optimal timing of the primary series is crucial to maintain optimal antibody levels during the period between the primary series and the boost...
The implementation of infant rotavirus vaccination has substantially reduced gastroenteritis hospitalizations among U.S. children and adults. Significant reductions were observed across all age groups, with the greatest declines seen in the late winter and early spring of 2008-2010.
Researchers found African-American women are 18.2% less likely to get vaccinated compared to white counterparts, despite access to healthcare. The study suggests health providers should bolster recommendations and address negative attitudes toward the vaccine.
A new study estimates the average cost per case of drug-resistant TB in the EU, revealing significant economic burden and support for investing in more effective vaccines. The study found that the costs of treating MDR-TB and XDR-TB cases exceed €170,000 and €170,000 respectively.
A randomized phase II trial is investigating a personalized vaccine made from a patient's own brain tumor, combined with Avastin, for treating recurrent glioblastoma multiforme. The trial aims to extend survival and slow tumor progression, offering new hope for patients with limited treatment options.